Furthermore, a study analyzing infused TIL products in melanoma patients receiving adoptive cell therapy revealed that neoantigen-specific T cell clones were predominantly CD4+ and displayed cytotoxicity [35]. This evidence concerns the gene CD4 and melanoma.